2 trial results announced this day (US Eastern).
| Time (ET) | Drug / result | Company | Outcome | Before | 24h later | 24h move |
|---|---|---|---|---|---|---|
| 8:05 AM | DT120 Generalized Anxiety Disorder | Definium Therapeutics (DFTX) | Met | $40.91 | $43.40 | +6.09% |
| 8:30 AM | NEO100 Recurrent IDH1-Mutant High-Grade Glioma | NeOnc Technologies (NTHI) | Met | $4.35 | $3.44 | −20.91% |
For information only. Not investment or medical advice. Prices are historical, from consolidated market data, and may contain errors. Always check the original source.